This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Your saved search

Name of saved search:

Search terms:

Would you like email updates of new search results?

Email: (change)

Frequency:

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Published Erratum

. 2024 Jan;20(3):159-161.

doi: 10.2217/fon-2022-1196c1. Epub 2024 Feb 7.

No authors listed

Published Erratum

No authors listed. Future Oncol. 2024 Jan.

. 2024 Jan;20(3):159-161.

doi: 10.2217/fon-2022-1196c1. Epub 2024 Feb 7.

No abstract available

Design of SERENA-6, a phase III switching trial of camizestrant in ESR1-mutant breast cancer during first-line treatment.
Turner N, Huang-Bartlett C, Kalinsky K, Cristofanilli M, Bianchini G, Chia S, Iwata H, Janni W, Ma CX, Mayer EL, Park YH, Fox S, Liu X, McClain S, Bidard FC. Turner N, et al. Future Oncol. 2023 Mar;19(8):559-573. doi: 10.2217/fon-2022-1196. Epub 2023 Apr 18. Future Oncol. 2023. PMID: 37070653